Insider · CIK 0001501240

Niederhuber John

Reports to the SEC for 2 companies · SEATTLE, WA

sec.gov

Transactions

Companies

Filings

CIK

0001501240

Forms 4 and 5

Insider transactions

42 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+400 sh	—	—	400
2026-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−400 sh	—	—	0
2025-08-06	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+7,200 sh	—	—	7,200
2025-07-17	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+1 sh	—	—	1
2025-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−1 sh	—	—	0
2024-07-17	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+925 sh	—	—	925
2024-06-02	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+81 sh	—	—	217
2024-06-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−81 sh	—	—	0
2024-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7 sh	—	—	136
2024-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−7 sh	—	—	0
2023-08-09	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+3,571 sh	—	—	5,682
2023-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−3,571 sh	—	—	0
2023-06-02	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+3,571 sh	—	—	3,571
2023-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+297 sh	—	—	2,111
2023-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−297 sh	—	—	298
2022-08-09	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+3,571 sh	—	—	3,571
2022-06-01	APVOAptevo Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+298 sh	—	—	1,814
2022-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−298 sh	—	—	595
2021-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,678 sh	—	—	2,678
2021-06-01	APVOAptevo Therapeutics Inc. · Restricted Stock UnitA Award	Director	AAward	+893 sh	—	—	893
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,339 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−892 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,785 sh	—	—	0
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+1,322 sh	—	—	1,322
2020-07-27	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+170 sh	—	—	170
2020-07-02	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+3,571 sh	—	—	3,571
2019-06-14	APVOAptevo Therapeutics Inc.P Purchase	Director	PPurchase	+714 sh	$0.91	+$649.74	1,516
2019-06-01	APVOAptevo Therapeutics Inc. · Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-06-01	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-01	APVOAptevo Therapeutics Inc. · Employee Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2016-08-03	APVOAptevo Therapeutics Inc. · Stock Option (right to buy)A Award	Director	AAward	+18.8K sh	—	—	18,750
2016-05-18	EBSEmergent BioSolutions Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,833 sh	—	—	22,467
2016-05-18	EBSEmergent BioSolutions Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−7,833 sh	—	—	30,300
2015-05-21	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+9,400 sh	—	—	30,300
2013-05-23	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+3,600 sh	—	—	16,200
2013-05-23	EBSEmergent BioSolutions Inc. · Director stock option (right to buy)A Award	Director	AAward	+7,200 sh	—	—	7,200
2012-05-17	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+3,600 sh	—	—	12,600
2012-05-17	EBSEmergent BioSolutions Inc. · Director Stock Option (Right to buy)A Award	Director	AAward	+7,200 sh	—	—	7,200
2011-05-19	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+3,600 sh	—	—	9,000
2011-05-19	EBSEmergent BioSolutions Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+7,200 sh	—	—	7,200
2010-08-23	EBSEmergent BioSolutions Inc.A Award	Director	AAward	+5,400 sh	—	—	5,400
2010-08-23	EBSEmergent BioSolutions Inc. · Director Stock Option (right to buy)A Award	Director	AAward	+10.8K sh	—	—	10,800

Recent filings

Accepted (ET)
Aug 104
Niederhuber John0001193125-26-343065
SEC(opens sec.gov)
Aug 84
Niederhuber John0000950170-25-105933
SEC(opens sec.gov)
Jul 214
Niederhuber John0000950170-25-097274
SEC(opens sec.gov)
Jul 194
Niederhuber John0000950170-24-084947
SEC(opens sec.gov)
Jun 34
Niederhuber John0000950170-24-068075
SEC(opens sec.gov)
Aug 104
Niederhuber John0001209191-23-045306
SEC(opens sec.gov)
Jun 24
Niederhuber John0001209191-23-033835
SEC(opens sec.gov)
Aug 104
Niederhuber John0001209191-22-045181
SEC(opens sec.gov)
Jun 34
Niederhuber John0001209191-22-033928
SEC(opens sec.gov)
Jun 24
Niederhuber John0001019056-21-000359
SEC(opens sec.gov)

Companies

Address

2401 4TH AVENUE SUITE 1050

SEATTLE, WA, 98121